Relationship between the efficiency of cholesterol absorption and apolipoprotein E (apoE) phenotype was studied in a random sample of middle-aged Finnish men. Subjects that were either heterozygous or homozygous for the allele e2 absorbed less and synthesized more cholesterol than those with the phenotype E4/3 and E4/4, the values for the individuals with the most frequent phenotype E3/3 (56% of the population sample) falling in between. Among the whole study group, the sum of the subscripts ofapoE phenotype (e.g., E2/3 = 5) was correlated positively with the fractional absorption of cholesterol (r = 0.40; P < 0.05) and negatively with the serum level of lathosterol, a cholesterol precursor sterol reflecting the activity of cholesterol synthesis (r = -0.48; P < 0.01). Thus, apoE polymorphism appears to affect the efficiency of cholesterol absorption and may by this mechanism contribute to the variation in plasma total and low density lipoprotein cholesterol concentration.
Introduction
Several population studies have indicated that apolipoprotein E (apoE)' polymorphism influences plasma lipid levels (1) (2) (3) (4) (5) . Thus, subjects with the most frequent apoE phenotype E3/3 have lower plasma total and low density lipoprotein (LDL) cholesterol levels than those with E4/3 and E4/4 phenotypes, but higher levels than subjects with heterozygosity and particularly homozygosity for the E2 allele. Recent studies have also shown that the variation in plasma total and LDL cholesterol concentration within the population is clearly determined by both LDL catabolism and synthesis (6) , which, in turn, at least among the Finns, are regulated by the efficiency of cholesterol absorption (7) . Thus, subjects with plasma cholesterol values in the highest decile have a higher fractional cholesterol absorption than those with the cholesterol values in the lowest decile (7) . Receivedfor publication 23 December 1986 and in revisedform 23 April 1987.
1. Abbreviation used in this paper: apo, apolipoprotein.
effective cholesterol absorption and increased e4 allele frequency among the subjects with high plasma cholesterol levels prompted us to consider that apoE polymorphism influences intestinal absorption of cholesterol and consequently leads to variation in plasma cholesterol concentration. This hypothesis was tested by relating the efficiency ofcholesterol absorption to the apoE phenotype in a random sample of Finnish men, a population characterized by a unique distribution of apoE alleles (3) , a high serum cholesterol concentration, and a high incidence of coronary heart disease (8).
Methods
Subjects. A random sample of 300 men aged 35-50 yr were identified from a population register in Helsinki. A fasting serum sample was obtained and analyzed for plasma lipids and lipoproteins. The limits for the lowest, modal, and highest deciles of LDL cholesterol were defined, and 13 subjects from each decile were recalled for the detailed analysis. The study population did not include any subjects with tendon xanthomata, which indicates that patients with familial hypercholesterolemia were most likely absent. No attempts were made to identify or exclude the presence of other types of primary hyperlipidemia. All the subjects volunteered for the studies, which had been approved by the Ethical Committee of our hospital.
Diet. All the subjects were studied while on their regular home diet. (±SEM) and are considered to be significant if P < 0.05.
Results
The distribution of apoE phenotypes among the subjects studied is shown in Table I . Of the 39 subjects 56% had the phenotype E3/3; 33%, the phenotype E3/4 or E4/4; and 10% were heterozygous or homozygous for the allele e2. The distribution roughly corresponds to that found in the Finnish population (3). To relate cholesterol absorption to apoprotein E isoforms, the subjects were divided into three groups: first, persons either homozygous or heterozygous for the e2 allele, designated as E2 subjects (n = 4); second, those with E3/3 (n = 22); and third, subjects with the phenotype E4/4 or E3/4 (n = 13), designated as E4 subjects.
The mean plasma total cholesterol concentration was lower in the subjects with E2 (4.7±0. 3 [±SE] mmol/liter) than in those with the phenotype E3/3 (6.1±0.3 mmol/liter) or in the E4 patients (6.9±0.3 mmol/liter). Also, the LDL cholesterol level in the E3/3 group was higher than that in the E2/2-4 subjects, but insignificantly lower than that in the patients with E4/4-3. Age, body-mass index (weight/height2), and other lipid values were quite similar in the three groups. However, the E2 and E4 homozygotes had somewhat elevated very low density lipoprotein (VLDL) cholesterol and total triglyceride levels. The dietary intakes of cholesterol in terms of milligrams/day per kilogram were not significantly different in the E2 (6.4±0.5), E3/3 (5.5±0.5), and E4 subjects (6.5±0.6) (analysis of variance, F value of 1.67). Also, the ratio of polyunsaturated to saturated fatty acids in dietary fat was similar in the three groups (0.34±0.05, 0.31+0.04, and 0.28±0.04, respectively) (analysis of variance; F value of 1.27).
The homozygous E3/3 subjects had a higher percent absorption of cholesterol than the patients with E2 (P < 0.05); the E4 subjects having the highest values (Fig. 1) . In fact, a positive correlation was observed between the percentage absorption of cholesterol and the sum of the subscripts of apoE (e.g., E2/3 = 5) (r = 0.40; P < 0.05) among all the subjects. The serum content ofcampesterol, another indicator ofcholesterol absorption (16) , was only insignificantly lower in the subjects with E2 (162±14 ,mol/mmol of cholesterol) than in those with E3/3 (171±12) or E4 (197±30).
The findings for bile acid and cholesterol synthesis were opposite to those found for cholesterol absorption. Thus, the subjects with E4 tended to have lower bile acid and cholesterol synthesis than those with E3/3 and particularly E2 (Fig. 1 ). These differences did not reach statistical significance, but the serum content of a cholesterol precursor sterol, lathosterol, a sensitive indicator of the activity of cholesterol synthesis (17, 18) , was significantly lower in the subjects with E4 than in those with E3/3 or E2 (P < 0.05) (Fig. 1) . Also, the serum content of lathosterol was negatively correlated with the sum of the subscripts of apoE (r = -0.48; P < 0.01) among all the subjects. Finally, the ratio of serum lathosterol to campesterol, which takes into account both the activity of cholesterol synthesis and the efficiency of cholesterol absorption was higher in the subjects with E2 (1.13±0.03) than in those with E4 (0.77±0.10) (P < 0.01), the mean values for the subjects with E3/3 (1.08±0.14) falling in between (analysis of variance; F value of 3.22).
Discussion
The genetic polymorphism ofapoE is controlled by three alleles, e2, e3, and e4, at a single gene locus (19, 20) . The amino acid substitutions in the main isoproteins have been characterized, and these differences change the affinity of apoE-containing lipoproteins for lipoprotein receptors, so that the affinity of apoE2 is lower than that of E3 and E4 (21) (22) (23) . Another important aspect of the apoE polymorphism is the effects of its alleles on serum cholesterol levels. Thus, in several populations, including the Finns, the e2 allele is associated with low and the e4 allele, with high plasma total cholesterol, LDL cholesterol, and apoB levels ( 1-4). Recent reports have also indicated that the metabolism oftriglyceride-rich lipoproteins and the kinetics ofplasma apoE itselfare markedly influenced by the apoE phenotype (24) (25) (26) , the plasma apoE concentration being lower in a homozygote for E4 than E3 (26) . The present study demonstrates that variations at the apoE locus may also affect the efficiency ofintestinal cholesterol absorption. All these metabolic events may be explained by a single mechanism, i.e., different recognition ofapoE isoforms by cell receptors for apoE-containing lipoproteins. Low density lipoprotein cholesterol mmol/l
How might apoE regulate the intestinal absorption of cholesterol? The mechanisms can only be a matter of speculation at the moment. The apoE alleles may regulate the transport of cholesterol into the cells, including the hepatocytes, because the hepatic receptor recognition of apoE2-containing lipoproteins is lower than that of apoE3 and apoE4 (22, 23) . ApoE may also function in the reverse transport of cholesterol from the peripheral cells to the liver for excretion (27, 28) . ApoE seems to be important in the transport of cholesterol from cholesterol-loaded macrophages (29) , and it has been proposed that apoE acts as a shuttle protein to transport cholesterol between various tissues (30). The transport of cholesterol as chylomicrons from the intestinal mucosal cells to the lymph and the liver could be shuttled by mechanisms involving apoE, when apoE polymorphism might also affect this metabolic pathway. ApoE synthesis appears to be negligible in the rat intestinal mucosa (31, 32) . If the same is true in man, it is difficult to reconcile the present findings with a direct action of apoE at the intestinal mucosal level. If circulating apoE is involved, the shuttling could take place in the mesenteric capillaries as well as in the lymphatics since apoE is also present in lymph. ApoE's regulatory effect on cholesterol absorption efficiency could also be mediated by some unknown secondary messenger, e.g., through a biliary signal from the liver to the intestinal mucosa.
Whatever the mechanism that mediates the association of the apoE phenotype and the efficiency ofcholesterol absorption, note that the absorption percentage seems to rise in parallel with the plasma LDL cholesterol level, which, in turn, is related to the apoE phenotype. It can be speculated that this association may disappear ifthe study population is heterogeneous including, e.g., subjects with familial hypercholesterolemia with completely different mechanisms for high serum cholesterol levels. The presence of subjects with familial-combined hyperlipidemia, other primary hyperlipidemias, or even both genders may similarly distort this relationship.
The observed relationship between the LDL level and cholesterol absorption and the inverse relation between the cholesterol absorption and the activity of cholesterol synthesis in the various apoE phenotypes are in good agreement with the pre- vious findings that the more effectively the hepatocytes are loaded with cholesterol, the less actively the cholesterol is synthesized and the lower is the hepatic LDL (B/E) receptor activity (33, 34) . The latter should result in a decreased clearance of LDL from the plasma and subsequently, in elevated LDL levels (33) . This was confirmed in the present study. The subjects with homozygosity and heterozygosity for E2 were poor absorbers of cholesterol, their cholesterol synthesis was high and their plasma LDL levels were low, whereas the E4 patients absorbed cholesterol effectively, had high LDL cholesterol concentrations, and their cholesterol synthesis was low. These findings also indicate that overall cholesterol input (the sum of synthesized plus absorbed dietary cholesterol) may not be associated with the LDL cholesterol concentration, LDL metabolism, or apoE polymorphism because effective absorption reduces cholesterol synthesis. Actually, the calculations on the cholesterol input rates in our patients are in good agreement with the previous work (35) , which shows that cholesterol input is not influenced by various apoE isoforms.
Our data would suggest that the LDL receptor activity and clearence of LDL from the plasma are most likely high in the E2 subjects and low in the patients with E4. In fact, recent results show that the clearance of LDL apoB is also related to the apoE phenotype, the subjects with E3/3 having a lower clearance rate than those with E2, but higher than the subjects with E4 (36) (37) (38) . Overall, these data suggest that it may be the variation among the various apoE phenotypes in the absorption of cholesterol and in the uptake of chylomicron remnants that determines the variation of LDL cholesterol concentration associated with the apoE polymorphism. 
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